Sweden’s Omnio raises €2.9 million to advance its plasminogen-based therapy for hard-to-heal chronic wounds
Omnio, a Umeå-based biotech startup, has raised €2.9 million to further develop its plasminogen-based therapy targeting chronic wounds. This funding follows a previous round, enabling the company to progress towards…
EU-Startups Sweden Read story →